<DOC>
	<DOCNO>NCT00343278</DOCNO>
	<brief_summary>Valaciclovir ( VACV ) , L-valyl ester prodrug aciclovir ( ACV ) , extensively convert ACV L-valine oral administration . In subject normal renal function , ACV predominantly eliminate unchanged urine , small proportion metabolize 9-carboxymethoxymethylguanine ( CMMG ) . The metabolism ACV CMMG think involve aldehyde dehydrogenase ( ALDH ) . On basis high proportion Japanese population low-activity ALDH , hypothesize conversion ACV CMMG decrease , thereby leading , patient renal impairment , high plasma concentration ACV . This pilot study conduct investigate potential relationship genetic polymorphism ALDH2 , isozyme ALDH , plasma pharmacokinetics ( PK ) VACV , ACV CMMG subject end-stage renal disease hemodialysis .</brief_summary>
	<brief_title>Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion criterion : Japanese subject chronic renal failure undergo hemodialysis regularly three time week least 12 week prior start study . Exclusion criterion : Subjects current alcohol dependence . Subjects gastrointestinal dysfunction may affect drug absorption . Subjects receive organ transplant ( However , subject corneal transplant organ transplant may affect objective study eligible inclusion study ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Valaciclovir Hydrochloride</keyword>
	<keyword>hemodialysis patient</keyword>
	<keyword>ALDH</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Japanese</keyword>
</DOC>